• 佛墙vp

    Uniting stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of—and future access to—an HIV vaccine

    Learn moreStrategic Plan
    Diagram of the plan

A renewed Strategic Plan

Uniting stakeholders to share knowledge, foster collaboration, enable solutions and to support the most critical issues, risks and challenges faced by the field

Increasing resources

Mobilizing new funding to support and grow the field of HIV vaccine research and development

赛·风4 for android

Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts

佛墙vp

佛墙vp

/in News /by

With over 600 virtual sessions and events, AIDS 2023: Virtual will enable delegates to access and engage with the latest HIV science, advocacy and knowledge traditionally presented at the conference, while offering a range of new features made possible by the new virtual format. Biomedical prevention interventions have saved lives and helped prevent new HIV infections. However, declines in incidence remain far from UNAIDS targets. A safe and globally effective HIV vaccine remains a necessity for a durable control and end to the epidemic. Download the HIV vaccine, and vaccine research roadmap.

Read more

佛墙vp

佛墙vp

/in Events /by

This scientific and technical workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID. Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs.

Read more

佛墙vp

In 2012, the Enterprise launched Timely Topics in HIV Vaccines, a strategy series convening experts as rapidly as possible to analyze, address, and respond to unresolved and emerging priority issues in the field. Through an open call for proposals, the Enterprise is working to identify the most important strategic needs of the field and sponsoring think tanks, meetings, forums and other events to tackle these issues.
Submit a timely topic

佛墙vp

C. Bickel, Science Translational Medicine; National Institute of Allergy and Infectious Diseases

佛墙vp

Book case (illustration)

佛墙vp

African children (illustration)

2nd Infant Trials Workshop

賽风官网下载

Knowns and Unknowns of Assaying ADCC against HIV

佛墙vp

Sign up to receive the latest news of the Vaccine Enterprise and occasional information related to IAS activities related to vaccine research and development (Please read our Privacy Policy)

© Copyright - The Global HIV Vaccine Enterprise - Enfold Theme by Kriesi
Scroll to top
WP Twitter Auto Publish Powered By : XYZScripts.com
    • 极光vp永久官网  酷通加速器苹果版  老王lite 加速器  登lnstagram的加速器  雷电模拟器怎么用SSR  海豚加速器白金破解版  sgreen无限试用  蜜蜂加速器价格表